| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Norway | 4 | |
| #2 | Australia | 3 | |
| #3 | Canada | 3 | |
| #4 | EPO (European Patent Office) | 3 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 | |
| #6 | African Regional Industrial Property Organization | 1 | |
| #7 | African Intellectual Property Organization | 1 | |
| #8 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Measuring microorganism processes | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Skaug Kjell | 8 |
| #2 | Berg Einar Sverre | 8 |
| #3 | Harbak Kari | 6 |
| #4 | Nord Karin | 6 |
| #5 | Rosenqvist Einar | 6 |
| #6 | Aase Audun | 5 |
| #7 | Naess Lisbeth Meyer | 4 |
| #8 | Grinde Bjoern | 2 |
| #9 | Noss Lisbeth Meyer | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AP200202681A0 | Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup A and process for the production thereof. | |
| US6114155A | Internal control and method for surveillance of Gap-LCR |